Riparian Pharmaceuticals inks license and research agreement with Pfizer for cardiovascular programs
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22
The 'A+' rating reflects IOL's robust business model, diversified product portfolio
As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands
Ensitrelvir is an oral antiviral that suppresses the replication of SARS-CoV-2 by selectively inhibiting the viral 3CL protease.
This patent-pending, high-efficiency chromatography media is used for the purification of novel peptide-based pharmaceuticals in the GLP-1 agonist class including type 2 diabetes and obesity treatments
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
Acquisition accelerates Cosette’s women’s health portfolio; with a differentiated, commercial stage, patent protected product
The judicial response to industry lawsuits on drug pricing regulations have been mixed in the past
Two patents were filed during the quarter ended 31st March, 2023 and the cumulative filings till date are 3239
Subscribe To Our Newsletter & Stay Updated